Gyre Therapeutics
GYRE
#7564
Rank
A$0.69 B
Marketcap
A$6.36
Share price
-6.86%
Change (1 day)
-45.59%
Change (1 year)

P/S ratio for Gyre Therapeutics (GYRE)

P/S ratio as of November 2026 (TTM): 3.91

According to Gyre Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.28. At the end of 2026 the company had a P/S ratio of 5.87.

P/S ratio history for Gyre Therapeutics from 2024 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20265.877.05%
20255.49-45.69%
202410.1